Koers Aradigm Corporation Nasdaq
Aandelen
US0385054004
Biotechnologie & Medisch Onderzoek
Omzet 2016 | 195K 180K | Omzet 2017 | 14,46 mln. 13,36 mln. | Marktkapitalisatie | 97,3 mln. 89,86 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -32 mln. -29,55 mln. | Nettowinst (verlies) 2017 | -10 mln. -9,24 mln. | EV/omzet 2016 | 73,3 x |
Nettoliquiditeiten 2016 | 9,37 mln. 8,66 mln. | Nettoschuld 2017 | 7,91 mln. 7,31 mln. | EV/omzet 2017 | 7,27 x |
K/w-verhouding 2016 |
-0,72
x | K/w-verhouding 2017 |
-9,3
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 60,28% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,03% | 49,18 mld. | |
-0,10% | 42,11 mld. | |
+47,13% | 40,37 mld. | |
-5,26% | 28,85 mld. | |
+11,48% | 26,09 mld. | |
-22,74% | 18,71 mld. | |
+9,06% | 13,26 mld. | |
+30,01% | 12,32 mld. | |
-1,51% | 11,99 mld. |